INFO and Contacts
- Available RSS sources
- Contacts
- Sitemap
- Terms of use
- Data privacy policy
- Accessibility
+ Accreditation
- Accreditation system
- Confidentiality policies
- Regolamento utilizzo strumentazione

LAERTE Laboratory, area Energy Efficiency

You are in the menu dedicated to energy efficiency.

Home LAERTE, Energy Efficiency

LAERTE research units

LAERTE Projects

Available results

Available services

Equipments

Bibliography

Energy Efficiency area Links

Staff

Technological Innovation ATLAS of ENEA

Regional Research Catalogue (HTN)

Regional Equipments Catalogue (HTN)

How to do to...

Roveri Smart Village

HTN Linkedin Group

The regional network

Projects

>List of all the projects

Strengthening the European Chain of sUpply for next generation medical RadionuclidEs

Acronym

SECURE

Large_Description

SECURE project aims to make a major contribution to the sustainability of medical isotope production and its safe application in Europe. It is focusing on promising developments in the design of irradiation targets, production routes for existing and new isotopes in nuclear therapy and diagnostics. Isotopes critical in the success of nuclear medicine are selected and research activities are identified to address some of the major challenges in securing its future availability, with the objectives: 1. to remove critical barriers along the production of its selected alpha and beta emitting isotopes that restrict a sustainable production; 2. to develop a framework of guidance and recommendations that enables exploring the full clinical potential of alpha and beta particle therapy and its safe application; 3. to provide important lessons learned that act as a demonstration case for addressing issues in upscaling and sustained isotope production. At present, Ra-223 is the only radiopharmaceutical which has been granted marketing authorization to treat adults with prostate cancer. This has paved the way for a wider use of other alpha emitters such as Ac-225 or Bi-213. The expected demand of nuclear medicine for novel alpha emitters and beta- emitters requires re-evaluation of their production methods and inventories of target materials and parent radionuclides. The ambition of SECURE consortium is to identify and efficiently use the current resources for new radionuclides, in particular for alpha emitters and the relevant beta emitting theranostic radionuclides. The development of alternative technologies for production of such therapeutic radionuclides for improved patient treatment requires multidisciplinary scientific and technological knowledge including physics, chemistry, material science, machining of target materials, chemistry, biology and radiobiology, radiopharmacy and nuclear medicine. All this chain of expertise is present in SECURE consortium.

start_date

01/10/2022

end_date

30/09/2025

url_reference

https://enen.eu/index.php/portfolio/secure-project/

Keywords

Medical Research; NUCLEAR FISSION; Radiation And Radioisotope Effects On Man, Animals, Plants And Microorganisms

Development_Status

In Progress

Funding

European

Keywords

Medical Research; NUCLEAR FISSION; Radiation And Radioisotope Effects On Man, Animals, Plants And Microorganisms

S3 Area

Life and welness Traiectory Innovazione nei processi industriali e in sanità

Platform

Life sciences

Project_Type

R&D

Partnerships

Research Unit	Name	Laboratory	Role
MATMA	Materiali in campo medicale ed ambientale	Home page Traceability laboratory	Scientific/Technical coordinator